Birmingham, United States
CIRCULOGENE, with the slogan "Patients deserve the BEST," is a molecular diagnostics company based in Birmingham, Ala. Founded in 2015, the company is led by a team of experienced industry executives and skilled molecular diagnostics scientists.
The company's innovative approach involves the application of a proprietary laboratory-developed test for cfDNA, cfRNA, and MSI liquid biopsies. Their cutting-edge next-generation sequencing (NGS) method allows for full genomic load analysis from a single standard tube of blood within one week. This breakthrough enables more accurate data, helping clinicians and their patients make informed decisions regarding targeted therapies, monitor efficacy, and track potential recurrence.
It's worth noting that CIRCULOGENE's comprehensive approach encompasses somatic and germline analysis, covering blood, tissue, and buccal samples, and includes the study of DNA, RNA, MSI, and PD-L1.
The company's most recent financial activity involved a Debt Financing investment on 24 March 2023. Details about the investors involved in this particular round of funding are not publicly available at this time.
Contact Information: General Inquiries: [email protected] Asia Pacific Inquiries: [email protected] Middle Eastern Inquiries: [email protected]
Industries: Biotechnology, Health and Wellness.
